← Eichor
Condition: Oral Cancers Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Oral Cancers

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT07180901Spectroscopic Analysis of Tongue Tumor Samples.
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05104619DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
Phase 2 · 5 location(s) · Hopital Foch · NCT06757244A Study of TYK-00540 in Adult Patients With Solid Tumors
Phase 1 · 1 location(s) · TYK Medicines, Inc · NCT06246071Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administ
Phase 1/Phase 2 · 8 location(s) · SNIPR Biome Aps. · NCT06938867AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Phase 1 · 13 location(s) · Carna Biosciences, Inc. · NCT05602363Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924Maintenance Zanzalintinib With Etoposide After HDCT in GCT
Phase 1/Phase 2 · 1 location(s) · Indiana University · NCT06937866AI-based Physiotherapy for Oral Cancer Patients
NA · 2 location(s) · National Taiwan University Hospital · NCT06785051Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
NA · 1 location(s) · University of Wisconsin, Madison · NCT07343596Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
NA · 3 location(s) · Tata Memorial Hospital · NCT05774483TES RCT Fleet Enema vs Oral Mechanical Bowel Prep
Phase 4 · 1 location(s) · Nova Scotia Health Authority · NCT05148494Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell L
Phase 2 · 23 location(s) · Xynomic Pharmaceuticals, Inc. · NCT03936153Validation of the O-bridge Protocol: a Prospective, Multicenter Trial
Phase N/A · 5 location(s) · AZ Sint-Jan AV · NCT04007783Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
NA · 20 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05892354Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Im
Phase 1 · 22 location(s) · Taiho Oncology, Inc. · NCT04953910A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Ca
Phase 3 · 205 location(s) · Merus B.V. · NCT06525220Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the Ex
NA · 4 location(s) · Institut Claudius Regaud · NCT05757817Estimating Jaw, Neck, and Shoulder Range of Motion Using an AI Model
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06629038A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensi
Phase N/A · 13 location(s) · AbbVie · NCT05317494Rice Bran Supplementation for Radiation-Induced Oral Mucositis in Head and Neck Cancer
NA · 1 location(s) · Christina Milad Lobos · NCT07242859Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
Phase 1/Phase 2 · 12 location(s) · Artios Pharma Ltd · NCT05898399Exogenous Ketone Supplementation in Females with Polycystic Ovary Syndrome
NA · 1 location(s) · McGill University · NCT06155708Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myast
Phase 3 · 145 location(s) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of M · NCT06463587The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Phase 3 · 73 location(s) · American Society of Clinical Oncology · NCT06377852Impact of Changing the Appearance of Oral Antineoplastics on Adherence and Continuity of Treatment, Patient-reported Hea
Phase N/A · 1 location(s) · Universidad Miguel Hernandez de Elche · NCT07664683Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Phase N/A · 1 location(s) · Viome · NCT05451303Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation
Phase 2 · 1 location(s) · Heidelberg University · NCT04214366
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.